VOLUNTARY ANNOUNCEMENT - IBS TM Coronary Scaffold System Obtained CE Certification under the EU MDR
Filed with HKEX · Stock code 1302 · · 4 pages · English
Summary by 6ix AI
LifeTech Scientific Corporation has announced that its IBS™ Coronary Scaffold System has obtained CE certification under the EU Medical Device Regulation, marking it as the first iron-based coronary scaffold authorized for commercial sale. The company plans to initiate a large-scale randomized controlled post-market study in Europe to further validate the clinical evidence for the product.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
LifeTech Scientific Corporation on 6ix
Earlier from LifeTech Scientific
- VOLUNTARY ANNOUNCEMENT - Admission of the ICS Elpis Bioresorbable Peripheral Balloon-Expandable Covered Scaffold System into Special Examination and Approval Procedure for Innovative Medical Devices
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
- VOLUNTARY ANNOUNCEMENT - Admission of the SureCham TM Aortic Arch Single-Branch Stent Graft System into Special Examination and Approval Procedure for Innovative Medical Devices
- LifeTech Scientific Corporation Announces 2026 Interim Results
- LifeTech Scientific Corporation Announces 2025 Annual Results: Steady Revenue Growth with Adjusted Net Profit Increasing 24.9%
Later from LifeTech Scientific
- Monthly return of equity issuer on movements in securities for the month ended 31 October 2026
- Termination of the framework agreement
Follow LifeTech Scientific into a list and get an email when it puts out news.
Follow LifeTech Scientific